Connect with us

Hi, what are you looking for?

Tuesday, Dec 7, 2021
Mugglehead Magazine
Cannabis & psychedelics industry news based in Vancouver, B.C.
  • Loading stock data...

The weed wire

Company e-learning platform to help UK doctors get up to speed on weed

A partnership with cannabis firm Khiron will teach physicians how to prescribe for pain, anxiety, cancer and epilepsy

UK doctors to get up to speed on weed
Medical student smiling at the camera during class at the university

Latin America-based cannabis company Khiron Life Sciences, Corp. (TSX-V: KHRN) is partnering with stakeholders in the United Kingdom’s health system to bring the country’s doctors up to speed on weed.

On Tuesday the company said it signed an agreement with the U.K.’s Medical Cannabis Clinicians Society to teach participating doctors through Khiron’s cloud-based learning platform. The platform is currently used by universities and institutions in Latin America.

The MCCS is an independent non-profit organization that helps create transparent, independent guidance around medical weed, as well as help patients access cannabis in a safe, legal and effective way, according to its website.

The U.K. legalized medical cannabis in 2018 but that doesn’t mean doctors automatically know how it can be prescribed to benefit patients, Khiron Europe president Tejinder Virk said in a statement.

“A lack of doctor education has been missing in growing the U.K. medical cannabis market and we are pleased to participate in helping the medical community overcome this barrier,” Virk said.

Classes will kick off in the third fiscal quarter of 2020. According to the statement, doctors will learn about:

  • U.K.-specific regulatory considerations,
  • clinical evidence and research,
  • safety and drug interactions,
  • clinical cases,
  • and practical recommendations for how to use cannabis to treat things like chronic pain, anxiety, cancer and epilepsy.

Lennox Gastaut syndrome and Dravet syndrome are two severe early-onset epileptic disorders that can be treated using Epidiolex, a cannabis-derived medication, as an adjunct therapy. Spasticity caused by multiple sclerosis can be treated with Sativex, another cannabis-derived medication. Both medications were approved for use by the U.K.’s National Institute for Health and Care Excellence last November.

Read more: U.K. approves 2 cannabis-based medicines 

Citing a report by Prohibition Partners, Khiron says there’s a large market in the U.K. for medical cannabis. In the U.K. over 1.4 million people are self-medicating using unregulated cannabis for chronic pain alone, Khiron said. Its regulated market is predicted to grow to 340,000 patients and be worth around $1.7 billion (£1 billion) by 2024, Khiron added.

But granting doctors the ability to prescribe these medications doesn’t retroactively change a doctor’s education about weed. That’s where Khiron steps in.

Getting doctors up to speed on medical weed is “critically important” to ensure doctors can prescribe safe and effective medical cannabis prescriptions, says MCCS chairperson Mike Barnes.

Partnering with Khiron is invaluable to society to help improve patients’ quality of life, Barnes added.

Read more: Clinical cannabis protocol being developed for Canadian doctors

Khiron is a medical and consumer packaged goods company operating in Latin America, Europe and North America. According to the firm, it is the leading cannabis company in Colombia and the first company in the country licensed for the cultivation, production, domestic distribution and international export of THC medical weed exports.

Its online doctor education program is designed to “drive prescription and brand loyalty to address priority medical conditions.”

On Thursday company stock rose 4 per cent to $0.50 per share.

Top image via Deposit Photos

 

michelle@mugglehead.com

@missmishelle

1 Comment

1 Comment

  1. Michele Medley

    August 26, 2020 at 8:34 am

    I was diagnosed with multiple sclerosis in 2014 but had my first symptoms in 2012. both my legs were spasming mostly at night which made sleeping difficult. I tried Copaxone for about 5 years or so. The Copaxone causes joint pain, I have tried several types of medications but all made me sick. In 2019 I went to a care facility, life was too difficult at home for my husband and family. I was advised by one of the nurse at the care facility to try natural treatments, She introduced me to Mayaka Herbal Clinic, spoke to my husband about it and he went online to research, My husband read lots of positive reviews from other people who used the product from Mayaka Clinic, We decided to start me on the treatment. Its been 7 months since I completed the treatment, It has made a tremendous difference for me. all my symptoms including poor vision, pain, fatigue, and other symptoms stopped Visit Mayaka Herbal Clinic website ww w . mayakaherbalclinic .com

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Health and Safety

Science doesn't know yet, but one psychedelic researcher is chasing clues to see if it can

Canada

As more medium-to-small producers came into play this year, great weed started hitting legal shelves at fairer prices

Culture

Punishments for possession include caning and the death penalty. Despite a global trend of reform, The Fine City remains staunch in its anti-drug stance

Analysis

While legal weed businesses decry enforcement of their accounts, the platform says it's keeping its all-ages community safe